Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany

被引:25
|
作者
Sauerbrei, A. [1 ]
Wutzler, P. [1 ]
机构
[1] Univ Jena, Inst Virol & Antiviral Therapy, D-07745 Jena, Germany
关键词
varicella-zoster virus; genotyping; wild-type strains; open reading frames 38; 54; and; 62; R5 repeat region;
D O I
10.1002/jmv.20879
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The general use of the varicella vaccine requires the surveillance of va rice I la-zoster virus (VZV) strains in patients infected with VZV. This paper reports the data achieved from a prospective study of genotyping VZV in Germany, analyzing the restriction fragment length polymorphism (RFLP) of the open reading frames (ORF) 38, 54, and 62 as well as the polymorphism of the R5 repeat region. The study included 177 patients with varicella. Seventy-eight patients with zoster served as controls. Results revealed that 78% of VZV strains in patients with varicella had the genetic profile of the dominant wild-genotype occurring in Europe and 22% had the markers of African or Asian strains. Varicella patients with the profile of African or Asian strains were significantly younger than patients with varicella caused by the dominant genotype. By contrast, all zoster patients exhibited strains representing the majority of wild-type strains in Europe. In conclusion, VZV strains from patients with varicella have a significantly higher genetic variability than viral strains from zoster patients. Since variants with the markers of African or Asian strains could only be found in young children with chickenpox, the results suggest a changing scene of VZV genotypes in Germany. As reasons, the spread of viruses, which may be imported originally by persons immigrating from warmer climates, or the recombination between wild-and vaccine-type viruses have to be considered.
引用
收藏
页码:1025 / 1031
页数:7
相关论文
共 50 条
  • [31] Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany
    Miriam Wiese-Posselt
    Anette Siedler
    Annette Mankertz
    Andreas Sauerbrei
    Hartmut Hengel
    Ole Wichmann
    Christina Poethko-Müller
    BMC Infectious Diseases, 17
  • [32] The Biology of Varicella-Zoster Virus Replication in the Skin
    Tommasi, Cristina
    Breuer, Judith
    VIRUSES-BASEL, 2022, 14 (05):
  • [33] CHEMOTHERAPY OF VARICELLA-ZOSTER VIRUS-INFECTIONS
    SNOECK, R
    ANDREI, G
    DECLERCQ, E
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1994, 4 (03) : 211 - 226
  • [34] SEROEPIDEMIOLOGY OF VARICELLA-ZOSTER VIRUS INFECTION IN ALBANIA
    Bejtja, Gazmend
    Robo, Alma
    Harxhi, Arjan
    INTERNATIONAL JOURNAL OF ECOSYSTEMS AND ECOLOGY SCIENCE-IJEES, 2015, 5 (02): : 213 - 216
  • [35] Varicella-Zoster Virus Infection and Osteomyelitis of the Skull
    Sommer, Taylor
    Karsy, Michael
    Driscoll, Meghan J.
    Jensen, Randy L.
    WORLD NEUROSURGERY, 2018, 115 : 297 - 300
  • [36] Penetrating keratoplasty for varicella-zoster virus keratopathy
    Tanure, MAG
    Cohen, EJ
    Grewal, S
    Rapuano, CJ
    Laibson, PR
    CORNEA, 2000, 19 (02) : 135 - 139
  • [37] Varicella-zoster virus infection and autonomic dysfunction
    Sakakibara, Ryuji
    Sawai, Setsu
    Ogata, Tsuyoshi
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2022, 242
  • [38] Varicella-Zoster Virus Vaccine: Molecular Genetics
    Schmid, D. Scott
    VARICELLA-ZOSTER VIRUS, 2010, 342 : 323 - 340
  • [39] Molecular Aspects of Varicella-Zoster Virus Latency
    Depledge, Daniel P.
    Sadaoka, Tomohiko
    Ouwendijk, Werner J. D.
    VIRUSES-BASEL, 2018, 10 (07):
  • [40] Fatal varicella due to the vaccine-strain varicella-zoster virus
    Leung, Jessica
    Siegel, Subhadra
    Jones, James F.
    Schulte, Cynthia
    Blog, Debra
    Schmid, D. Scott
    Bialek, Stephanie R.
    Marin, Mona
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (01) : 146 - 149